[Incidence and mortality of laryngeal cancer in China, 2014]
- PMID: 30392337
- DOI: 10.3760/cma.j.issn.0253-3766.2018.10.004
[Incidence and mortality of laryngeal cancer in China, 2014]
Abstract
Objective: To estimate the incidence and mortality of laryngeal cancer in China based on the cancer registration data in 2014, collected by the National Central Cancer Registry (NCCR), and to provide support data for the control and prevention of laryngeal cancer. Methods: The incident and death data of laryngeal cancer in 2014 from 339 cancer registries met the quality criteria of NCCR, and then adopted for analysis. The incident and death number, crude rate, age standardized rate, truncated rate and proportion which stratified by areas (urban/rural) and age were calculated. The nationwide incidence and mortality of laryngeal cancer in 2014 were estimated by combining with those data on national population in 2014. Chinese population census in 2000 and Segi's population were used for age-standardized incidence/mortality rates. Results: It was estimates that 23.4 thousand new cases of laryngeal cancer occurred in China in 2014. There were 20.8 thousand males and 2.6 thousand females. And 14.5 thousand occurred in urban areas, while 8.9 thousand in rural areas. The age standardized rates of incidence by world standard population (ASRs world) in male, female and both genders were 2.05/100, 000, 0.24/100, 000 and 1.14/100, 000, respectively, whereas those were 1.22/100, 000 and 1.03/100, 000 for urban and rural areas. The incidence was much higher in males than females, and slightly higher in urban areas than those in rural areas. Moreover, it was estimates that 13.2 thousand death cases of laryngeal cancer occurred in China in 2014. There were 11.5 thousand males and 1.7 thousand females. And 7.8 thousand occurred in urban areas, while 5.4 thousand in rural areas. The age standardized rates of mortality by ASRs world in male, female and both genders were 1.08/100, 000, 0.14/100, 000 and 0.60/100, 000, respectively, whereas those were 0.60/100, 000 and 0.59/100, 000 for urban and rural areas. The mortality was much higher in males than females, and slightly higher in urban areas than those in rural areas. In males, the age specific incidence and mortality of laryngeal cancer increased greatly from 40-44 and 45-44 years old, respectively, and peaked at age group of 75-79 and >85 years old. In females, the age specific incidence and mortality increased slowly from 50-54 and 60-64 years old, respectively, and peaked at age group of 80-84 and >85 years old. The trends remained similar in urban and rural areas, except for the different peak ages. Conclusions: The incidence and mortality of laryngeal cancer in China are at middle-low levels worldwide, and there are obvious differences between urban and rural areas with distinct gender disparity. Comprehensive prevention and control strategies should be carried out according to local status and age groups.
目的: 分析全国肿瘤登记中心收集的2014年喉癌资料,估计2014年全国喉癌发病和死亡情况。 方法: 对符合质量要求的339个肿瘤登记处2014年的喉癌数据进行分析,计算其发病和死亡数、粗率、年龄标化率、截缩率和构成比等。按城乡和年龄分层,结合2014年全国人口数据,估计2014年全国喉癌发病和死亡概况。中国人口标化率(中标率)采用2000年全国人口普查的标准人口年龄构成,世界人口标化率(世标率)采用Segi′s标准人口年龄构成。 结果: 估计2014年全国喉癌发病2.34万例,其中男性2.08万例,女性0.26万例,城市地区1.45万例,农村地区0.89万例,男、女和合计发病世标率分别为2.05/10万、0.24/10万和1.14/10万,城市和农村地区分别为1.22/10万和1.03/10万,男性发病明显高于女性,城市地区略高于农村。估计2014年全国喉癌死亡1.32万例,其中男性1.15万例,女性0.17万例,城市地区0.78万例,农村地区0.54万例,男、女和合计死亡世标率分别为1.08/10万、0.14/10万和0.60/10万,城市和农村地区死亡世标率分别为0.60/10万和0.59/10万,男性死亡率明显高于女性,城市地区死亡率略高于农村地区。男性喉癌发病和死亡分别从40~44岁和45~49岁后开始迅速上升,75~79岁和>85岁达高峰,女性分别从50~54岁和55~59岁后缓慢上升,80~84岁和>85岁达高峰,城市和农村变化趋势相同,只是高峰年龄有所不同。 结论: 2014年我国喉癌发病和死亡位于全球中低水平,且存在明显城乡和性别差异,应根据实际情况制订正确的防治措施。.
Keywords: China; Incidence; Laryngeal neoplasm; Mortality.
Similar articles
-
[Incidence and mortality of bladder cancer in China, 2014].Zhonghua Zhong Liu Za Zhi. 2018 Sep 23;40(9):647-652. doi: 10.3760/cma.j.issn.0253-3766.2018.09.002. Zhonghua Zhong Liu Za Zhi. 2018. PMID: 30293387 Chinese.
-
[Estimation on the incidence and mortality of kidney cancer in China, in 2014].Zhonghua Liu Xing Bing Xue Za Zhi. 2018 Oct 10;39(10):1346-1350. doi: 10.3760/cma.j.issn.0254-6450.2018.10.011. Zhonghua Liu Xing Bing Xue Za Zhi. 2018. PMID: 30453435 Chinese.
-
Incidence and mortality of laryngeal cancer in Zhejiang cancer registry, 2000-2011.J Cancer Res Ther. 2015 Oct;11 Suppl 2:C155-60. doi: 10.4103/0973-1482.168177. J Cancer Res Ther. 2015. PMID: 26506868
-
Prevalence of type 2 diabetes mellitus among inland residents in China (2000-2014): A meta-analysis.J Diabetes Investig. 2016 Nov;7(6):845-852. doi: 10.1111/jdi.12514. Epub 2016 Apr 27. J Diabetes Investig. 2016. PMID: 27181391 Free PMC article.
-
A comparative epidemiologic study of fractures among people in rural and urban areas.Injury. 2020 Aug;51(8):1784-1790. doi: 10.1016/j.injury.2020.05.018. Epub 2020 May 29. Injury. 2020. PMID: 32522358 Review.
Cited by
-
Experience of individualized nursing in patients with laryngeal squamous cell carcinoma combined with Helicobacter pylori infection after surgery.J Cancer Res Clin Oncol. 2023 Aug;149(9):6575-6582. doi: 10.1007/s00432-023-04627-z. Epub 2023 Feb 14. J Cancer Res Clin Oncol. 2023. PMID: 36781505 Free PMC article.
-
Signature microRNAs and long noncoding RNAs in laryngeal cancer recurrence identified using a competing endogenous RNA network.Mol Med Rep. 2019 Jun;19(6):4806-4818. doi: 10.3892/mmr.2019.10143. Epub 2019 Apr 10. Mol Med Rep. 2019. PMID: 31059106 Free PMC article.
-
Radiotherapy Versus Surgery-Which Is Better for Patients With T1-2N0M0 Glottic Laryngeal Squamous Cell Carcinoma? Individualized Survival Prediction Based on Web-Based Nomograms.Front Oncol. 2020 Aug 26;10:1669. doi: 10.3389/fonc.2020.01669. eCollection 2020. Front Oncol. 2020. PMID: 33014833 Free PMC article.
-
Trend and projection of larynx cancer incidence and mortality in China from 1990 to 2044: A Bayesian age-period-cohort modeling study.Cancer Med. 2023 Aug;12(15):16517-16530. doi: 10.1002/cam4.6239. Epub 2023 Jun 12. Cancer Med. 2023. PMID: 37306154 Free PMC article.
-
LncRNA-MALAT1: A Key Participant in the Occurrence and Development of Cancer.Molecules. 2023 Feb 24;28(5):2126. doi: 10.3390/molecules28052126. Molecules. 2023. PMID: 36903369 Free PMC article. Review.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous